The Problem: Lack of Private Incentives to Repurpose Off-Patent Drugs Millions of lives could be saved if drug companies weren’t limited by a patent model that dates back to the 15th century [1]. The problem is that when the patent on a drug runs out, drug prices plummet, creating a…

Following on from the Global Financial Crisis (GFC), governments around the world have been looking for innovative ways to make a bigger impact with their available funds and to address the paradox that investing in R&D to improve delivery of public goods and services can save taxpayer money, but that…

Crowd Funded Cures (www.crowdfundedcures.org), a New Zealand based charity, is commissioning a high-level feasibility study conducted by Guidehouse (formerly, the public consulting arm of PwC) to use financial innovation to incentivise development of Unmonopolisable Therapies and Unprofitable Therapies using Pay for Success Contracts such as Social Impact Bonds (SIBs) or…